Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Phillips

Showing results (951-960 of 976) with videos related to

Pageof 98
Sort By:
Clinical Trials (London, England)|October 11, 2021
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.
The Lancet. Global Health|September 20, 2025
Effects of reductions in US foreign assistance on HIV, tuberculosis, family planning, and maternal and child health: a modelling studyJohn Stover, Emily Sonneveldt, Yvonne Tam, et al.
JAMA|July 13, 2016
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral TherapyAlison J Rodger, Valentina Cambiano, Tina Bruun, et al.
The Lancet. Global Health|November 16, 2024
Estimates of resource use in the public-sector health-care system and the effect of strengthening health-care services in Malawi during 2015-19: a modelling study (Thanzi La Onse)Timothy B Hallett, Tara D Mangal, Asif U Tamuri, et al.
Medrxiv : the Preprint Server for Health Sciences|November 20, 2020
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.
Lancet (London, England)|May 7, 2019
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational studyAlison J Rodger, Valentina Cambiano, Tina Bruun, et al.
The Lancet. HIV|January 15, 2023
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling studyJennifer Smith, Loveleen Bansi-Matharu, Valentina Cambiano, et al.
Proteins|August 24, 2019
Target highlights in CASP13: Experimental target structures through the eyes of their authorsRosalba Lepore, Andriy Kryshtafovych, Markus Alahuhta, et al.
Archives of Internal Medicine|March 10, 2010
Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years, Rebecca Lodwick, Dominique Costagliola, et al.
The Lancet. HIV|April 30, 2022
Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling studyAndrew N Phillips, Anna Bershteyn, Paul Revill, et al.
Pageof 98

Showing results (951-960 of 976) with videos related to

Sort By:
Pageof 98
Clinical Trials (London, England)|October 11, 2021
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.
The Lancet. Global Health|September 20, 2025
Effects of reductions in US foreign assistance on HIV, tuberculosis, family planning, and maternal and child health: a modelling studyJohn Stover, Emily Sonneveldt, Yvonne Tam, et al.
JAMA|July 13, 2016
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral TherapyAlison J Rodger, Valentina Cambiano, Tina Bruun, et al.
The Lancet. Global Health|November 16, 2024
Estimates of resource use in the public-sector health-care system and the effect of strengthening health-care services in Malawi during 2015-19: a modelling study (Thanzi La Onse)Timothy B Hallett, Tara D Mangal, Asif U Tamuri, et al.
Medrxiv : the Preprint Server for Health Sciences|November 20, 2020
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.
Lancet (London, England)|May 7, 2019
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational studyAlison J Rodger, Valentina Cambiano, Tina Bruun, et al.
The Lancet. HIV|January 15, 2023
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling studyJennifer Smith, Loveleen Bansi-Matharu, Valentina Cambiano, et al.
Proteins|August 24, 2019
Target highlights in CASP13: Experimental target structures through the eyes of their authorsRosalba Lepore, Andriy Kryshtafovych, Markus Alahuhta, et al.
Archives of Internal Medicine|March 10, 2010
Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years, Rebecca Lodwick, Dominique Costagliola, et al.
The Lancet. HIV|April 30, 2022
Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling studyAndrew N Phillips, Anna Bershteyn, Paul Revill, et al.
Pageof 98